{
  "topic": "Biomarkers in Psychology and Psychiatry",
  "questions": [
    {
      "question": "Traditional psychological assessment primarily relies on:",
      "options": [
        "Genetic testing",
        "Behavior, self-report, and clinical judgment",
        "Neuroimaging only",
        "Computational modeling"
      ],
      "correct": 1,
      "feedback": "Psychology has traditionally relied on behavior, self-report, and clinical judgment."
    },
    {
      "question": "What key limitation motivates interest in biomarkers?",
      "options": [
        "Lack of technology",
        "Excessive objectivity",
        "Subjectivity and limited predictive power",
        "High costs of assessment"
      ],
      "correct": 2,
      "feedback": "Biomarkers are pursued to address subjectivity and limited prediction."
    },
    {
      "question": "Biomarkers are expected to improve psychology by:",
      "options": [
        "Replacing clinicians",
        "Reducing subjectivity and improving prediction",
        "Eliminating uncertainty",
        "Providing causal explanations"
      ],
      "correct": 1,
      "feedback": "Their promise lies in objectivity, quantification, and prediction."
    },
    {
      "question": "According to the NIH/FDA definition, a biomarker is:",
      "options": [
        "A diagnosis",
        "A causal mechanism",
        "A measured characteristic indicating a biological process",
        "A subjective report"
      ],
      "correct": 2,
      "feedback": "A biomarker is a measured indicator, not a diagnosis or mechanism."
    },
    {
      "question": "A key implication of the biomarker definition is that biomarkers are:",
      "options": [
        "Direct explanations",
        "Context-independent",
        "Indirect indicators",
        "Always clinically useful"
      ],
      "correct": 2,
      "feedback": "Biomarkers are indirect and context-dependent."
    },
    {
      "question": "Why can an objective measure still be clinically useless?",
      "options": [
        "It is too expensive",
        "It lacks statistical significance",
        "There is large overlap between patients and controls",
        "It is not biological"
      ],
      "correct": 2,
      "feedback": "Large overlap reduces decision usefulness despite objectivity."
    },
    {
      "question": "Many proposed biomarkers fail clinically because they:",
      "options": [
        "Are too complex",
        "Lack statistical significance",
        "Do not add value over clinical judgment",
        "Are unethical"
      ],
      "correct": 2,
      "feedback": "Statistical significance alone does not guarantee usefulness."
    },
    {
      "question": "Why are one-to-one mappings between biomarkers and disorders rare?",
      "options": [
        "Measurement error",
        "Poor study design",
        "Biological and psychological complexity",
        "Lack of funding"
      ],
      "correct": 2,
      "feedback": "Psychological phenomena are heterogeneous and multidimensional."
    },
    {
      "question": "Most biomarkers should be understood as:",
      "options": [
        "Mechanisms",
        "Causes",
        "Probabilistic correlates",
        "Deterministic signals"
      ],
      "correct": 2,
      "feedback": "They are correlates, not causes or mechanisms."
    },
    {
      "question": "Why does group-level significance not guarantee individual usefulness?",
      "options": [
        "Groups are too small",
        "Clinical decisions are individual",
        "Statistics are unreliable",
        "Biomarkers change mechanisms"
      ],
      "correct": 1,
      "feedback": "Clinical decisions concern individuals, not group averages."
    },
    {
      "question": "Biomarkers should primarily function as:",
      "options": [
        "Decision-makers",
        "Diagnostic replacements",
        "Decision-support tools",
        "Causal explanations"
      ],
      "correct": 2,
      "feedback": "They support but do not replace clinical judgment."
    },
    {
      "question": "Which of the following can be a biomarker?",
      "options": [
        "Only genes",
        "Only brain imaging",
        "Behavioral measures",
        "Only molecular signals"
      ],
      "correct": 2,
      "feedback": "Behavioral and computational measures can be biomarkers."
    },
    {
      "question": "Which is NOT a biomarker by definition?",
      "options": [
        "Diagnosis",
        "Physiological signal",
        "Behavioral feature",
        "Computed score"
      ],
      "correct": 0,
      "feedback": "A diagnosis is not a biomarker."
    },
    {
      "question": "A Context of Use (CoU) specifies:",
      "options": [
        "Measurement noise",
        "Target population and question",
        "Statistical method",
        "Biological mechanism"
      ],
      "correct": 1,
      "feedback": "Biomarkers are only defined within a context of use."
    },
    {
      "question": "Without a defined CoU, a biomarkerâ€™s performance:",
      "options": [
        "Improves",
        "Can be generalized",
        "Cannot be meaningfully evaluated",
        "Becomes causal"
      ],
      "correct": 2,
      "feedback": "Usefulness depends on context."
    },
    {
      "question": "Biomarkers vary along multiple dimensions, including:",
      "options": [
        "Only biological level",
        "Only time",
        "Biological level, time, specificity, and function",
        "Only measurement accuracy"
      ],
      "correct": 2,
      "feedback": "Biomarkers are multidimensional objects."
    },
    {
      "question": "Lower biological level biomarkers are always:",
      "options": [
        "More objective",
        "More specific",
        "More useful",
        "Not necessarily better"
      ],
      "correct": 3,
      "feedback": "Lower-level does not guarantee usefulness."
    },
    {
      "question": "Trait biomarkers are typically:",
      "options": [
        "Highly variable",
        "Context-dependent",
        "Relatively stable",
        "Only behavioral"
      ],
      "correct": 2,
      "feedback": "Trait biomarkers show temporal stability."
    },
    {
      "question": "State biomarkers are characterized by:",
      "options": [
        "High stability",
        "Sensitivity to context",
        "Immunity to bias",
        "Genetic origin"
      ],
      "correct": 1,
      "feedback": "State biomarkers fluctuate with condition and context."
    },
    {
      "question": "A major limitation of trait biomarkers is that they are often:",
      "options": [
        "Too noisy",
        "Ethically problematic",
        "Weak predictors",
        "Unmeasurable"
      ],
      "correct": 2,
      "feedback": "They often have limited predictive power."
    },
    {
      "question": "Psychological biomarkers are often:",
      "options": [
        "Disorder-specific",
        "Mechanism-specific",
        "Transdiagnostic",
        "Genetically determined"
      ],
      "correct": 2,
      "feedback": "Many reflect shared processes across disorders."
    },
    {
      "question": "Measurement context affects biomarkers by influencing:",
      "options": [
        "Only cost",
        "Only ethics",
        "Reliability and validity",
        "Biological causality"
      ],
      "correct": 2,
      "feedback": "Context directly impacts measurement quality."
    },
    {
      "question": "A biomarker may work in the lab but fail clinically because:",
      "options": [
        "Labs use worse equipment",
        "Clinical settings are more variable",
        "Statistics change",
        "Mechanisms disappear"
      ],
      "correct": 1,
      "feedback": "Real-world conditions introduce variability."
    },
    {
      "question": "Reliability refers to:",
      "options": [
        "Causal explanation",
        "Consistency of measurement",
        "Clinical usefulness",
        "Ethical acceptability"
      ],
      "correct": 1,
      "feedback": "Reliability concerns measurement consistency."
    },
    {
      "question": "Why does reliability set an upper limit on usefulness?",
      "options": [
        "It limits sample size",
        "Unreliable measures produce spurious associations",
        "It changes mechanisms",
        "It reduces specificity"
      ],
      "correct": 1,
      "feedback": "Unreliable biomarkers cannot support decisions."
    },
    {
      "question": "Validity is best described as:",
      "options": [
        "A single property",
        "Independent of context",
        "Purpose-dependent",
        "Equivalent to reliability"
      ],
      "correct": 2,
      "feedback": "Validity depends on the intended use."
    },
    {
      "question": "Which type of validity is most relevant clinically?",
      "options": [
        "Face validity",
        "Construct validity",
        "Predictive validity",
        "Internal validity"
      ],
      "correct": 2,
      "feedback": "Clinical use depends on prediction."
    },
    {
      "question": "When classifying individuals, biomarkers can produce:",
      "options": [
        "Only correct decisions",
        "Only false positives",
        "Four types of outcomes",
        "Only probabilistic outputs"
      ],
      "correct": 2,
      "feedback": "Outcomes include TP, FP, TN, FN."
    },
    {
      "question": "A false positive means:",
      "options": [
        "Condition present but undetected",
        "Condition absent but indicated",
        "Correct exclusion",
        "Measurement failure"
      ],
      "correct": 1,
      "feedback": "False positives indicate a condition that is not present."
    },
    {
      "question": "False negatives are particularly harmful because they can lead to:",
      "options": [
        "Overdiagnosis",
        "Unnecessary treatment",
        "Missed diagnosis",
        "Increased specificity"
      ],
      "correct": 2,
      "feedback": "They result in missed or delayed intervention."
    },
    {
      "question": "Sensitivity refers to the ability to:",
      "options": [
        "Exclude absence",
        "Detect presence",
        "Balance errors",
        "Increase accuracy"
      ],
      "correct": 1,
      "feedback": "Sensitivity detects true positives."
    },
    {
      "question": "Increasing sensitivity often leads to:",
      "options": [
        "More false negatives",
        "More false positives",
        "Higher specificity",
        "Lower prevalence"
      ],
      "correct": 1,
      "feedback": "Higher sensitivity increases false positives."
    },
    {
      "question": "Specificity measures the ability to:",
      "options": [
        "Detect disease",
        "Exclude disease",
        "Predict outcomes",
        "Explain mechanisms"
      ],
      "correct": 1,
      "feedback": "Specificity concerns true negatives."
    },
    {
      "question": "Changing a biomarker threshold primarily affects:",
      "options": [
        "Biological mechanism",
        "Sample size",
        "Error balance",
        "Clinical context"
      ],
      "correct": 2,
      "feedback": "Thresholds trade sensitivity and specificity."
    },
    {
      "question": "ROC curves describe:",
      "options": [
        "Measurement noise",
        "Group differences",
        "Trade-offs across thresholds",
        "Causal pathways"
      ],
      "correct": 2,
      "feedback": "They visualize sensitivity vs false positives."
    },
    {
      "question": "High accuracy alone is insufficient because:",
      "options": [
        "It ignores biology",
        "It ignores error consequences",
        "It reduces specificity",
        "It inflates prevalence"
      ],
      "correct": 1,
      "feedback": "Clinical utility depends on consequences."
    },
    {
      "question": "Diagnostic biomarkers primarily answer:",
      "options": [
        "What will happen?",
        "Who is at risk?",
        "Is the condition present?",
        "Is treatment effective?"
      ],
      "correct": 2,
      "feedback": "They focus on classification."
    },
    {
      "question": "For diagnostic biomarkers, which error is especially harmful?",
      "options": [
        "False negatives",
        "False positives",
        "True positives",
        "True negatives"
      ],
      "correct": 1,
      "feedback": "False positives can cause overdiagnosis."
    },
    {
      "question": "Prognostic biomarkers provide information about:",
      "options": [
        "Current diagnosis",
        "Treatment response",
        "Future course",
        "Measurement error"
      ],
      "correct": 2,
      "feedback": "They predict disease trajectory."
    },
    {
      "question": "Predictive biomarkers are especially challenging because they require:",
      "options": [
        "Large samples only",
        "Comparison across treatments",
        "High specificity only",
        "Mechanistic understanding"
      ],
      "correct": 1,
      "feedback": "They must compare responses to different interventions."
    },
    {
      "question": "Monitoring biomarkers are used to:",
      "options": [
        "Diagnose disease",
        "Predict risk",
        "Track change over time",
        "Explain causality"
      ],
      "correct": 2,
      "feedback": "They assess progression or response."
    },
    {
      "question": "Risk biomarkers are associated with:",
      "options": [
        "Low uncertainty",
        "Few false positives",
        "Ethical concerns",
        "Immediate treatment decisions"
      ],
      "correct": 2,
      "feedback": "They raise issues of labeling and uncertainty."
    },
    {
      "question": "Clinical settings differ from laboratories because they involve:",
      "options": [
        "Better control",
        "Homogeneous patients",
        "High variability and emotional stakes",
        "Lower uncertainty"
      ],
      "correct": 2,
      "feedback": "Clinical reality is complex and constrained."
    },
    {
      "question": "In psychology and psychiatry, biomarkers should:",
      "options": [
        "Replace clinicians",
        "Eliminate judgment",
        "Support clinical decision-making",
        "Provide certainty"
      ],
      "correct": 2,
      "feedback": "They complement but do not replace clinicians."
    },
    {
      "question": "A positive biomarker result should be communicated as:",
      "options": [
        "Certain",
        "Deterministic",
        "Probabilistic",
        "Causal"
      ],
      "correct": 2,
      "feedback": "Biomarkers indicate probabilities, not certainties."
    }
  ]
}
